| Cost-effectiveness analysis of gene-based therapies for patients with spinal muscular atrophy type I in Australia T Wang, P Scuffham, J Byrnes, M Downes Journal of Neurology 269 (12), 6544-6554, 2022 | 10 | 2022 |
| Modelling a cost-effective vaccination strategy for the prevention of varicella and herpes zoster infection: A systematic review B Hodgkinson, T Wang, J Byrnes, P Scuffham Vaccine 39 (9), 1370-1382, 2021 | 4 | 2021 |
| Economic evaluation of reproductive carrier screening for recessive genetic conditions: a systematic review T Wang, M Bahrampour, J Byrnes, P Scuffham, E Kirk, M Downes Expert review of pharmacoeconomics & outcomes research 22 (2), 197-206, 2022 | 3 | 2022 |
| Clinical utility of reproductive carrier screening for preconception and pregnant couples for multiple genetic conditions: a systematic review and meta-analysis T Wang, D Kiss, K McFadden, J Byrnes, P Scuffham, MB Delatycki, ... Expert Review of Molecular Diagnostics 23 (5), 419-429, 2023 | 1 | 2023 |
| An overview of reproductive carrier screening panels for autosomal recessive and/or X‐linked conditions: How much do we know? T Wang, P Scuffham, J Byrnes, MB Delatycki, M Downes Prenatal Diagnosis 43 (11), 1416-1424, 2023 | | 2023 |
| The Economic Burden of Autosomal Recessive and X-Linked Conditions Associated with An Extensive Gene Panel Screening in Australia. T Wang, P Scuffham, J Byrnes, M Downes The 44th Australian Health Economics Society, 2023 | | 2023 |
| Doctorate Thesis: Health Economics of Reproductive Carrier Screening T Wang Griffith University, 2023 | | 2023 |
| Clinical utility of reproductive carrier screening for preconception and pregnant couples for multiple genetic conditions: a systematic review and meta-analysis T Wang, D Kiss, K McFadden, J Byrnes, P Scuffham, MB Delatycki, ... The 43rd Australian Health Economics Society, 2022 | | 2022 |
| Cost-Utility Analysis of Genetic Therapies in the Treatment of Patients with Spinal Muscular Atrophy in Australia. T Wang, P Scuffham, J Byrnes, M Downes 10th Australian Health Economics Society Doctoral (AHED) workshop (42nd …, 2021 | | 2021 |
| PRO2 Economic Evaluation of Reproductive Carrier Screening for Recessive Genetic Conditions: A Systematic Review T Wang, M Bahrampour, J Byrnes, P Scuffham, M Downes Value in Health Regional Issues 22, S95, 2020 | | 2020 |
| 26 Cost-Effectiveness Evaluations of Behavior Change Interventions T Wang, M Downes, J Byrnes, P Scuffham The Handbook of Behavior Change, 372, 2020 | | 2020 |
| Master Thesis: Decision Modelling of a Non-Pharmacological Intervention for Patients with Dementia T Wang The University of Queensland, 2018 | | 2018 |
| Decision Modelling Cost-Utility Analysis of the Tailored Activity Program (TAP) for Patients Living with Dementia and Their Caregivers. T Wang, B Gannon, S Bennett The 40th Annual Australian Health Economics Society Conference, 2018 | | 2018 |
| Master Thesis: Synthesis and Anti-Tumour Activity Studies of Tetrahydro-β-Carboline & Bis-Indole Compounds T Wang Tianjin University of Science & Technology, 2014 | | 2014 |
| Bis-indole compounds and synthetic method P Yu, T Wang, Y Wang, B Shi, W Deng, L Jiang, H Sun, Y Yang, B Song, ... CN Patent CN104,030,964 B, 2014 | | 2014 |
| Preparation of 1-(phenyl)-2,3,4,9-tetrahydro-1H-pyridino[3,4-b]indole derivatives and application of derivatives in antitumor drugs P Yu, Y Wang, S Jia, Haiyong, Wen, L Lei, N Guo, K Han, J Chu, T Wang CN Patent CN103,864,779 B, 2012 | | 2012 |
Joshua ByrnesGriffith UniversityVerified email at griffith.edu.au
